BACKGROUND: Patients with systemic lupus erythematosus seem to belong to different
serological and clinical subgroups of the disease. Genetic background can cause the …

Background To our knowledge there are no studies assessing anti-Ro/SSA and anti-La/SSB
autoantibodies in a large population of childhood-systemic lupus erythematosus (cSLE) …

In this in-depth review, we examine the worldwide epidemiology of SLE and summarize
current knowledge on the influence of race/ethnicity on clinical manifestations, disease activity, …

… All statistical analyses and graphs were performed using R 3.3.2 software. Data are presented
as mean (standard deviation) and median (first, third quartile) in the case of continuous …

In the course of Systemic Lupus Erythematosus (SLE), a variety of neuropsychiatric
disturbances is reported with a prevalence ranging from 17% to 75%. The diagnosis of these …

Objective. (1) To evaluate the spectrum of serum autoantibodies in pediatric-onset systemic
lupus erythematosus (pSLE) with a focus on ethnic differences; (2) using cluster analysis, to …

Background Evidence supports the existence of different subphenotypes in systemic lupus
erythematosus (SLE) and the pivotal role of cytokines and autoantibodies, which interact in a …

Neuroinflammation is a complex process that contributes to the pathogenesis of both immune
mediated and neurodegenerative pathologies. Systemic lupus erythematosus (SLE) is the …

Introduction Pediatric systemic lupus erythematosus (pSLE) patients often initially present
with more active and severe disease than adults, including a higher frequency of lupus …

Objective The risk of thrombosis is increased in patients with systemic lupus erythematosus (SLE).
Few studies have assessed factors associated with thrombosis within the pediatric …